Atlas Trials

Docetaxel Combined With Cisplatin as First Line in Patients With Metastatic Non-small Cell Lung Cancer

Clinical trial NCT01356303 · SUSPENDED

Trial details

NCT number
NCT01356303
Sponsor
National Guard Health Affairs
Status
SUSPENDED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer Metastatic
Start date
2009-03-01
Primary completion
2016-08-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.